A team from NDM's Big Data Institute is sharing an epidemiological model to help configure a contact tracing app for coronavirus. The model offers several safe configurations to introduce an app and a framework to optimise the app after it is released. The simulations confirm that if around half the total population use the app, alongside other interventions, it has the potential to stop the epidemic and help to keep countries out of lockdown. These research efforts are supporting several European projects including the UK’s national programme led by NHSX, a joint unit comprised of teams from NHS England and the Department of Health & Social Care.
The world’s largest randomised clinical trial of potential coronavirus treatments is well underway in the UK as part of the race to find a treatment. A number of promising treatments are being tested and, if the science supports it, will be given to NHS patients as quickly as possible. The trial is being coordinated by NDM's Peter Horby, Professor of Emerging Infectious Diseases and Global Health and Martin Landray, Professor of Medicine and Epidemiology at the Nuffield Department of Population Health.
A team of medical researchers and bioethicists at Oxford University has published results today in Science that further our understanding of coronavirus transmission. Professor Christophe Fraser from the Big Data Institute, Nuffield Department of Medicine, a lead author on the Science paper explains, “We need a mobile contact tracing app to urgently support health services to control coronavirus transmission, target interventions and keep people safe".
A team of medical research and bioethics experts are supporting several European governments to explore the feasibility of a coronavirus mobile app for instant contact tracing. BDI's Professor Christophe Fraser explains, 'The instant mobile app concept is very simple. If you are diagnosed with coronavirus, the people you’ve recently come into contact with will be messaged advising them to isolate. If this mobile app is developed enough people opt-in, we can slow the spread of coronavirus.
Many congratulations to Prof Alison Simmons, who has been awarded a Wellcome Trust Investigator Award. Alison Simmons is a Professor of Gastroenterology in NDM and the MRC Human Immunology Unit, and was recently elected a Fellow of the Academy of Medical Sciences. The Simmons lab works on Inflammatory Bowel Disease (IBD), a debilitating condition that affects more than 300,000 people in the UK. In IBD, the protective barrier that separates gut luminal microbes from the mucosal immune system is disrupted, leading to inflammation.
If you have news or events that you would like to be added to this website, please email us details. If possible, please include a picture and links to further information.